20 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
.
On August 8, 2022, we announced that we have received approval from the MoH and Ethics Committee of Soroka Medical Center to conduct our clinical … Inventory, respectively.
On August 8, 2022, we announced that we have received approval from the MoH and Ethics Committee of Soroka Medical Center to conduct
6-K
EX-99.1
SPRC
SciSparc Ltd
17 Jul 23
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
8:00am
in Israel, including approvals from the Soroka University Medical Center Ethics Committee and Israeli Ministry of Health.
The Company’s goal is to sell
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
it received approval from the Ethics Committee of The Soroka University Medical Center, in Be’er-Sheva, Israel, to conduct the Company’s clinical trial.
“We
6-K
EX-99.1
fliu4l7khf
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
6-K
pjl62q3 y3qdx
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
znn6hg6pb2qur
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
048v ft8qszn
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
6-K
i43x4ge1j
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
424B4
uct6oq4qqlsu
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
73pv6 dmtxp
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
v4h8ez 2l
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
28gfcadm bznnmls
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
5mfyfpg0
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
20-F
xf8vnwyfoss 96l
1 May 17
Annual report (foreign)
12:00am
- Prev
- 1
- Next